slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1
slide1 slide1 slide1

Lectures on SIMDAX

Use of levosimendan in Acute decompensated heart failure

Use of Levosimendan in Cardiac surgery

Use of Levosimendan in Advanced heart failure

Use of Levosimendan in Intensive and Critical Care

Lectures at ESC 2019

 

I.V. Inodilators: why, when and how

 
Inodilators and Cardio-Renal Syndrome, P Agostoni & C Tschöpe Inodilators in Acute Heart Failure/Cardiogenic shock, F Gustafsson & VP Harjola
Take home message: I.V. Inodilators: why, when and how, J Parissis  
 

Lectures at ESC Heart Failure 2019


 
The Acute Heart Failure settings  
Guidelines and definition of AHF, therapeutic options, García-Pinilla, José M. (Spain) Role of hemodynamic active drugs, differential effects of drug families, von Lewinski, Dirk
Clinical practice in AHF with different etiologies, Parissis, John  
   
Differential renal effects of vasoactive drugs  
Cardio-renal syndrome, Zima, Endre Differential renal effects of levosimendan on renal function in AHF, Reinecke, Alexander
Differential renal effects of vasoactive drugs - Clinical practice, Karason, Kristjan  
   
AHF or CS as a consequence of Acute Coronary Syndrome  
Therapeutic options and clinical practice for ACS-induced AHF, Recio-Mayoral, Alejandro Therapeutic options and clinical practice for ACS-induced cardiogenic shock, Harjola, Veli-Pekka
AHF or CS as a consequence of Acute Coronary Syndrome - Clinical practice, Farmakis, Dimitrios  
   

Lectures at ESC 2018

 
Inotropes in Acute Heart Failure: from guidelines to practical use - Guidelines and patient characteristics, D. von Lewinski (AT), ESC 2018 Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Cardio-renal syndrome, F. Fedele (IT), ESC 2018
   
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Cardio-renal syndrome, F. Gustafsson (DK), ESC 2018 Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - What is available? G. Giannakoulas (GR), ESC 2018
   
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice, R.H. Schwinger (DE), ESC 2018 Inotropes in Acute Heart Failure: from guidelines to practical use - Therapeutic options and clinical practice, F. Fruhwald (AT), ESC 2018
   
Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators? Patient characteristics, V-P Harjola (FI), ESC 2018 Acute Heart Failure related to acute coronary syndromes: is there a role for inodilators? Therapeutic options, C. Tschöpe (DE), ESC 2018
   
Inodilators and renal function: how to avoid kidney dysfunction in Acute Heart Failure? - Therapeutic options and clinical practice, S. Matskeplishvili (RU), ESC 2018 Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - What is available? Z. Papp (HU), ESC 2018
   
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice, A. Borbély, (HU), ESC 2018 Inotropes in Acute Heart Failure: from guidelines to practical use - Therapeutic options and clinical practice, J. Parissis (GR), ESC 2018

   

Lectures at ESC Heart Failure 2018

 
Levosimendan in Acute Heart Failure: from guidelines to practical use - Patient characteristics, D. von Lewinski (AT), ESC-HF 2018 Levosimendan in Acute Heart Failure: from guidelines to practical use - Clinical practice and therapeutic options, G. Giannakoulas (GR), ESC-HF 2018
   
Levosimendan in HFrEF: on whom, when and how? - What is available? Z. Papp (HU), ESC-HF 2018 Levosimendan in HFrEF: on whom, when and how? - Therapeutic needs, V-P Harjola (FI), ESC-HF 2018
   
Levosimendan in HFrEF: on whom, when and how? - Clinical practice, J. Parissis (GR), ESC-HF 2018  
Take home message: I.V. Inodilators: why, when and how, J Parissis  

Interested in seeing more? Go to lecture archives for videos from congresses in 2017 and beyond.

 

Lectures at ISICEM 2019

 
Levosimendan as a first-line inotrope in cardiac surgery – Practical aspect, limitations and pitfalls, M. Heringlake (DE), ISICEM 2019  
 
   

Lectures at EACTA 2018

 
The LEVO-CTS and LICORN studies: co-analysis of the mortality results
in the isolated CABG patients, B. Cholley (FR), EACTA 2018
The LEVO-CTS and LICORN studies: evidence, recommendations, and
limitations for levosimendan, M. Heringlake (DE), EACTA 2018
   
The LEVO-CTS and LICORN studies in the light of the clinical practice, D. Bettex (CH), EACTA 2018  
 
   

Lectures at EACTA 2016

 
Levosimendan for optimising patient outcome in cardiac surgery, D. Bettex (CH), EACTA 2016 Effects of levosimendan on the renal function, S-E Ricksten (SE), EACTA 2016
   
   
Perioperative heart failure - still a challenge, M Siegemund (CH), EACTA 2016  
 
   

Lecture at ISICEM 2016

 
Levosimendan in cardiac surgery - a practical approach, S. Bouchez (BE), ISICEM 2016  
 

Interested in watching more videos on use of levosimendan in cardiac surgery? Go to lecture archives to see lectures from congresses 2015 and beyond.

 

Lectures at ESC 2019

 

I.V. Inodilators: why, when and how


 
Inodilators in Advanced Heart Failure: G Pölzl & J Comin-Colét  

 

Lectures at ESC Heart Failure 2019

 
Physiological effects of vaso-active drugs in AdHF? Agostoni, Piergiuseppe When does acute decompensation start? Pölzl, Gerhard

Lectures at ESC 2018

 
Repetitive use of inodilators in Advanced Heart Failure: Therapeutic options and clinical practice, Fabrizio Oliva (IT), ESC 2018 Repetitive use of inodilators in Advanced Heart Failure: Patient characteristics, Josep Comin-Colet (ES), ESC 2018
   
Repetitive use of inodilators in Advanced Heart Failure: Therapeutic options and clinical practice, Gerhard Pölzl (AT), ESC 2018  
 
   

Lectures at ESC Heart Failure 2018

 
Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Cardio-renal syndrome, Kristjan Karason (SE), ESC-HF 2018 Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Therapeutic options, Francesco Fedele (IT), ESC-HF 2018
   
Levosimendan and renal function: how to avoid kidney dysfunction in AHF? - Clinical practice, Finn Gustafsson (DK), ESC-HF 2018 Repetitive use of levosimendan in advanced heart failure - Scientific evidence in the literature, Carsten Tschöpe (GE), ESC-HF 2018
   
   
Repetitive use of levosimendan in advanced heart failure - Patient characteristics, Gerhard Pölzl (AU), ESC-HF 2018 Repetitive use of levosimendan in advanced heart failure - Clinical practice and new data, Fabrizio Oliva (IT), ESC-HF 2018
   
   

Interested in watching more videos on use of levosimendan in Advanced heart failure? Go to lecture archives for recordings of lectures from European clinical congresses from 2017 and beyond. 

 

Lectures at ESICM-LIVES 2019

 
Differential hemodynamic effects of i.v. inotropes, A Herpain Current and potential applications for a renal-friendly inotrope, M Girardis
Differential renal effects of i.v. inotropes, S-E Ricksten Levosimendan in the clinical use: evidence of renal effects, S Treskatsch

Lectures at ISICEM 2019

 
Decatecholaminization of ICU: Why and how? Fabio Guarracino (IT), ISICEM 2019 Levosimendan hemodynamic effects: Still unique in its kind? Antoine Herpain (BE), ISICEM 2019

   
Preoperative Levosimendan in CABG: A new analysis may shed more light, M. Heringlake (DE) Cardio-Renal interplay: Levosimendan as a kidney friendly inodilator, S-E Ricksten (SE)
   

Lectures at ESICM LIVES 2018

 
The inodilator levosimendan in ICU, A. Herpain (BE), ESICM LIVES 2018 Need for hemodynamic support in ICU, B. Cholley (FR), ESICM LIVES 2018
   

Levosimendan for weaning from ECMO, A. Combes (FR), ESICM LIVES 2018

Levosimendan and Cardiogenic shock, F. Brünger (DE), ESICM LIVES 2018

   
Levosimendan and Septic shock, caveat, B. Levy (FR), ESICM LIVES 2018 Levosimendan and Septic shock, when yes, M. Girardis (IT), ESICM LIVES 2018
   
   
Levosimendan in pulmonary hypertension and right ventricular dysfunction, H. Riha (CZ), ESICM LIVES 2018 Levosimendan and renal function, M. Leone (FR), ESICM LIVES 2018
   
   

Lectures at ISICEM 2018

 
Renal effects of levosimendan, S-E Ricksten (SE), ISICEM 2018 Is the prolonged action of levosimendan of relevance with our patient LoS and pathologies? A. Herpain, ISICEM 2018
   
The hemodynamic effects of levosimendan: which patient will benefit from them? F. Guarracino,  ISICEM 2018 Perioperative effects of levosimendan in CABG, M. Heringlake (DE), ISICEM 2018
   
   
Efficacy and safety of levosimendan in the light of clinical practice, S. Bouchez, ISICEM 2018  
 

 

Interested in seeing more videos on the use of levosimendan in intensive and critical care? Visit lecture archives to watch videos from congresses in 2017 and beyond.